In-Silico Drug Discovery Market, By Type, By Type of Large Molecule, By Workflow, By Target Therapeutic Area, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

In-Silico Drug Discovery market size was valued at US$ 3,804.9 Million in 2025, expanding at a CAGR of 19.2% from 2026 to 2033.

In silico drug discovery helps to identify new drug candidates through computational techniques such as molecular modelling and artificial intelligence. Large databases are used that have plenty of biological and chemical data. It allows the user to be able to model drug interactions with receptors and pharmacokinetics and toxicity. Using techniques such as virtual screening, molecular docking, and machine learning, the researcher is able to reduce many drug candidates to a few. It will reduce the time and resource consumption in drug discovery. In this way, in silico drug discovery technology increases the speed of discovery of new drug targets and increases the efficiency of initial drug design. Therefore, in silico drug discovery facilitates the drug discovery process using computational approaches.

In-Silico Drug Discovery Market- Market Dynamics

AI Adoption in Medicinal Chemistry to propel market demand

Increasing adoption of artificial intelligence (AI) and computational chemistry is accelerating in-silico drug discovery, which can speed up rapid design and screening of molecular compounds while predicting drug properties accurately. For instance, in June 2026, according to the UK government's AI Adoption Plan: Life Sciences, 48.4% of life sciences sector respondents said that they were adopting AI technologies in their organisation (based on a December 2025 survey). Drug discovery is one field where there is great potential for the usage of AI technology. It involves designing new molecules and predicting efficacy and toxicity. Initial modelling of AI R&D from discovery to preclinical development reveals savings in costs and time by 25-50%. This demonstrates how AI can be adopted in medicinal chemistry to speed up molecule design, optimise drug candidates.

In-Silico Drug Discovery Market- Segmentation Analysis:

The Global In-Silico Drug Discovery market is segmented on the basis of Type, Type of Large Molecule, Workflow, Target Therapeutic Area, End User, and Region.

Antibodies hold a key role in the In-Silico Drug Discovery market, as the demand for the analysis of antibodies, predicting binding interactions, and optimising the therapeutic candidates is rising. In July 2025, Charles River Laboratories collaborated with Isogenica to enhance the availability of their high-diversity VHH antibody and peptide discovery services. Hence, collaborations are assisting in the discovery of new antibodies.

In-Silico Drug Discovery Market- Geographical Insights

North America holds a prominent position in the In-Silico Drug Discovery market. This is because of the growing adoption of computational technologies using artificial intelligence and increasing investment into pharmaceutical research. For instance, in March 2026, according to a study published in Enquiry, titled "Artificial Intelligence Applicability in the Pharmaceutical Industry: Present Perspectives and Future Formations", 81.8% of people working in the pharmaceutical industry were aware of the uses of AI, while 70.5% had used AI technology in their fields of expertise. ChatGPT was the most common AI used in the pharmaceutical industry, making up 63.6%. Only 27.3% had seen AI being used in their respective organisations. The findings emphasise the potential for AI-powered computational platforms to support pharmaceutical research, drug development, and operational efficiency.

Germany In-Silico Drug Discovery market - Country Insights

The Germany In-Silico Drug Discovery market is growing steadily because of the highly advanced infrastructure within the pharmaceutical industry. Furthermore, increasing investments in computational biology, bioinformatics and artificial intelligence driven drug design is adding to the growth of the market. In August 2025, according to the U.S. Department of Commerce (Gov), Germany contributes about USD 838,000 million every year to the economic performance of the country and makes up 12.8 per cent of the country's total GDP.

There are 13,500 manufacturers and more than 265,000 employees working in the medical technology industry in Germany. The industry is earning about USD 63,800 million every year. In addition, the medical device market of Germany is generating revenue of about USD 44,000 million every year and makes up 26.5 per cent of the entire European market. This indicates that Germany has a highly developed medical infrastructure along with a well-established medical technology manufacturing industry.

In-Silico Drug Discovery Market- Competitive Landscape:

The In-Silico Drug Discovery market features competition of medium level, with leading service vendors and technology-focused firms battling to establish their dominance in the market. Leading vendors such as Certara, Inc., Charles River Laboratories International, Inc., Schrodinger, Inc., Chemical Computing Group ULC, and Insilico Medicine, which are working on computational modelling, AI-powered drug discovery, and molecular simulation. In January 2026, Schrodinger formed an alliance with Eli Lilly and Company's TuneLab platform to enable its AI drug discovery capabilities to be used in LiveDesign. This strategic alliance uses AI, physics-based computation, and experimental data to facilitate molecular design.

Recent Developments:

In May 2026, Simulations Plus announced a technical collaboration with NVIDIA to perform simulations on a GPU-accelerated platform and model drug discovery processes using AI tools. This will help to speed up computationally intensive processes by combining SIMPLUS' pharmacokinetic and quantitative systems pharmacology modelling solutions with NVIDIA's AI technology.

In January 2026, Insilico Medicine entered into an agreement with Qilu Pharmaceutical to discover and develop novel small-molecule inhibitors targeting cardiometabolic disease. Under the agreement, which is worth almost USD 120 million, Insilico will receive development and commercialisation milestones plus royalty payments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-SILICO DRUG DISCOVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Curia Global Inc.
Certara, Inc.
Charles River Laboratories International, Inc.
Chemical Computing Group ULC
GenScript
Schrodinger, Inc.
Insilico Medicine
Evotec SE
Atomwise, Inc.
Sygnature Discovery
Abzena Ltd.
BioNTech SE
Creative Biostructure
Nimbus Therapeutics
Dassault Systemes SE
Simulations Plus, Inc.
Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

Software as a Service (SaaS)
Consultancy as a Service
Software

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY TYPE OF LARGE MOLECULE- MARKET ANALYSIS, 2020 - 2033

Antibodies
Proteins
Peptides
Vectors
Nucleic Acids

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY WORKFLOW- MARKET ANALYSIS, 2020 - 2033

Target Identification
Reverse Docking
Bioinformatics
Protein Structure Prediction
Target Validation
Lead Discovery
Pharmacophore
Library Design
Clinical Trials
Preclinical Tests

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY TARGET THERAPEUTIC AREA- MARKET ANALYSIS, 2020 - 2033

Infectious Diseases
Metabolic Disorders
Mental Disorders
Musculoskeletal Disorders
Neurological Disorders
Respiratory Disorders
Skin Disorders
Urogenital Disorders
Autoimmune Disorders
Cardiovascular Disorders
Blood Disorders
Gastrointestinal Disorders
Hormonal Disorders
Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Contract Research Organizations
Academic and Research Institutes
Pharmaceutical Industry
Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV7722

1. In-Silico Drug Discovery Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
2.2. Competitive Insights

3. In-Silico Drug Discovery Key Market Trends

3.1. In-Silico Drug Discovery Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. In-Silico Drug Discovery Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. In-Silico Drug Discovery Market Opportunities
3.4. In-Silico Drug Discovery Market Future Trends

4. In-Silico Drug Discovery Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. In-Silico Drug Discovery Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. In-Silico Drug Discovery Market Landscape

6.1. In-Silico Drug Discovery Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. In-Silico Drug Discovery Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Software as a Service (SaaS)
- 7.1.3. Consultancy as a Service
- 7.1.4. Software

8. In-Silico Drug Discovery Market - By Type of Large Molecule

8.1. Overview
- 8.1.1. Segment Share Analysis, By Type of Large Molecule, 2025 & 2033 (%)
- 8.1.2. Antibodies
- 8.1.3. Proteins
- 8.1.4. Peptides
- 8.1.5. Vectors
- 8.1.6. Nucleic Acids

9. In-Silico Drug Discovery Market - By Workflow

9.1. Overview
- 9.1.1. Segment Share Analysis, By Workflow, 2025 & 2033 (%)
- 9.1.2. Target Identification
- 9.1.3. Reverse Docking
- 9.1.4. Bioinformatics
- 9.1.5. Protein Structure Prediction
- 9.1.6. Target Validation
- 9.1.7. Lead Discovery
- 9.1.8. Pharmacophore
- 9.1.9. Library Design
- 9.1.10. Clinical Trials
- 9.1.11. Preclinical Tests

10. In-Silico Drug Discovery Market - By Target Therapeutic Area

10.1. Overview
- 10.1.1. Segment Share Analysis, By Target Therapeutic Area, 2025 & 2033 (%)
10.2. Infectious Diseases
10.3. Metabolic Disorders
10.4. Mental Disorders
10.5. Musculoskeletal Disorders
10.6. Neurological Disorders
10.7. Respiratory Disorders
10.8. Skin Disorders
10.9. Urogenital Disorders
10.10. Autoimmune Disorders
10.11. Cardiovascular Disorders
10.12. Blood Disorders
10.13. Gastrointestinal Disorders
10.14. Hormonal Disorders
10.15. Others

11. In-Silico Drug Discovery Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.2. Contract Research Organizations
11.3. Academic and Research Institutes
11.4. Pharmaceutical Industry
11.5. Others

12. In-Silico Drug Discovery Market - By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. In-Silico Drug Discovery Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. In-Silico Drug Discovery Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. In-Silico Drug Discovery Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. In-Silico Drug Discovery Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. In-Silico Drug Discovery Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Type of Large Molecule, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By Target Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- In-Silico Drug Discovery Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Curia Global Inc.
- 13.2.2. Certara, Inc.
- 13.2.3. Charles River Laboratories International, Inc.
- 13.2.4. Chemical Computing Group ULC
- 13.2.5. GenScript
- 13.2.6. Schrodinger, Inc.
- 13.2.7. Insilico Medicine
- 13.2.8. Evotec SE
- 13.2.9. Atomwise, Inc.
- 13.2.10. Sygnature Discovery
- 13.2.11. Abzena Ltd.
- 13.2.12. BioNTech SE
- 13.2.13. Creative Biostructure
- 13.2.14. Nimbus Therapeutics
- 13.2.15. Dassault Systemes SE
- 13.2.16. Simulations Plus, Inc.
- 13.2.17. Others

14. 360 Degree AnalystView

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us